Lu Jiang

1.2k total citations
35 papers, 876 citations indexed

About

Lu Jiang is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Lu Jiang has authored 35 papers receiving a total of 876 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Molecular Biology and 6 papers in Immunology. Recurrent topics in Lu Jiang's work include PI3K/AKT/mTOR signaling in cancer (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Cancer, Lipids, and Metabolism (3 papers). Lu Jiang is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Cancer, Lipids, and Metabolism (3 papers). Lu Jiang collaborates with scholars based in China, Ethiopia and South Korea. Lu Jiang's co-authors include Xin Yin, Liheng Guo, Shuai Mao, Lihong Pan, Zhi‐Han Tang, Zhong Ren, Dangheng Wei, Zhi‐Sheng Jiang, Lushan Liu and Xuehui Liu and has published in prestigious journals such as PLoS ONE, Small and Science Advances.

In The Last Decade

Lu Jiang

33 papers receiving 859 citations

Peers

Lu Jiang
Weiping Zhang China
Iryna Voloshyna United States
Tomás P. Griffin Ireland
Jen‐Pi Tsai Taiwan
Takashi Dan Japan
Xiaohui Bian China
Guangju Guan China
In Hee Lee South Korea
Yi Song China
Weiping Zhang China
Lu Jiang
Citations per year, relative to Lu Jiang Lu Jiang (= 1×) peers Weiping Zhang

Countries citing papers authored by Lu Jiang

Since Specialization
Citations

This map shows the geographic impact of Lu Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Jiang more than expected).

Fields of papers citing papers by Lu Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lu Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Jiang. The network helps show where Lu Jiang may publish in the future.

Co-authorship network of co-authors of Lu Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Lu Jiang. A scholar is included among the top collaborators of Lu Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lu Jiang. Lu Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Min-Yu, Lijiang Wang, Zhanhui Du, et al.. (2023). Joint effect of maternal pre-pregnancy body mass index and folic acid supplements on gestational diabetes mellitus risk: a prospective cohort study. BMC Pregnancy and Childbirth. 23(1). 202–202. 3 indexed citations
2.
Zhang, Li, Xiaoping Li, Lu Jiang, et al.. (2021). The EGFR Polymorphism Increased the Risk of Hepatocellular Carcinoma Through the miR-3196-Dependent Approach in Chinese Han Population. Pharmacogenomics and Personalized Medicine. Volume 14. 469–476. 3 indexed citations
3.
4.
Wang, Jixian, Guofeng Li, Lidong Deng, et al.. (2021). Transcranial Focused Ultrasound Stimulation Improves Neurorehabilitation after Middle Cerebral Artery Occlusion in Mice. Aging and Disease. 12(1). 50–50. 40 indexed citations
5.
Jiang, Lu, Shuwei Li, Ming Yuan, et al.. (2020). Genetic variants in the Folic acid Metabolic Pathway Genes predict outcomes of metastatic Colorectal Cancer patients receiving first-line Chemotherapy. Journal of Cancer. 11(22). 6507–6515. 3 indexed citations
6.
7.
Zhu, Chengjun, et al.. (2020). The urokinase-type plasminogen activator and inhibitors in resectable lung adenocarcinoma. Pathology - Research and Practice. 216(4). 152885–152885. 5 indexed citations
8.
Jiang, Lu, et al.. (2018). Association of HLA-DPB1 polymorphisms with rheumatoid arthritis: A systemic review and meta-analysis. International Journal of Surgery. 52. 98–104. 11 indexed citations
9.
Yu, Jingping, Zhongling Wang, Changjie Pan, et al.. (2018). Comparative study of dual energy CT iodine imaging and standardized concentrations before and after chemoradiotherapy for esophageal cancer. BMC Cancer. 18(1). 1120–1120. 26 indexed citations
10.
Shen, Xiaomeng, Jing Yuan, Minghui Zhang, et al.. (2017). The increased expression of TCF3 is correlated with poor prognosis in Chinese patients with nasopharyngeal carcinoma. Clinical Otolaryngology. 42(4). 824–830. 9 indexed citations
11.
Jiang, Lu, et al.. (2017). Prognostic and clinical significance of claudin-1 in colorectal cancer: A systemic review and meta-analysis. International Journal of Surgery. 39. 214–220. 11 indexed citations
12.
Zhu, Qinyi, Lu Jiang, & Xipeng Wang. (2017). The expression of Duffy antigen receptor for chemokines by epithelial ovarian cancer decreases growth potential. Oncology Letters. 13(6). 4302–4306. 20 indexed citations
13.
Yuan, Yao, Xiaoyan Xie, Yuchen Jiang, et al.. (2017). LRP6 is identified as a potential prognostic marker for oral squamous cell carcinoma via MALDI-IMS. Cell Death and Disease. 8(9). e3035–e3035. 19 indexed citations
14.
Jiang, Lu, et al.. (2016). Hyperuricemia and contrast-induced acute kidney injury: A systematic review and meta-analysis. International Journal of Cardiology. 224. 286–294. 39 indexed citations
15.
Wu, Min, Yan Wu, Ting Lan, et al.. (2016). Type II cGMP-dependent protein kinase inhibits EGF-induced JAK/STAT signaling in gastric cancer cells. Molecular Medicine Reports. 14(2). 1849–1856. 8 indexed citations
16.
Liu, Xuehui, et al.. (2016). Hyperuricemia and coronary heart disease mortality: a meta-analysis of prospective cohort studies. BMC Cardiovascular Disorders. 16(1). 207–207. 120 indexed citations
17.
Feng, Yong, Zhenying Cai, Yuan Tang, et al.. (2014). TLR4/NF-κB signaling pathway-mediated and oxLDL-induced up-regulation of LOX-1, MCP-1, and VCAM-1 expressions in human umbilical vein endothelial cells. Genetics and Molecular Research. 13(1). 680–695. 38 indexed citations
18.
Jiang, Lu, Ting Lan, Yongchang Chen, et al.. (2013). PKG II Inhibits EGF/EGFR-Induced Migration of Gastric Cancer Cells. PLoS ONE. 8(4). e61674–e61674. 35 indexed citations
19.
Wang, Jiayi, Xiaoxu Li, Xin Jin, et al.. (2012). Associations Between Three Polymorphisms in the Interleukin-4 Receptor Gene and Risk of Cancer: a Meta-analysis. Asian Pacific Journal of Cancer Prevention. 13(12). 6227–6232. 4 indexed citations
20.
Tang, Zhi‐Han, Lu Jiang, Juan Peng, et al.. (2012). PCSK9 siRNA suppresses the inflammatory response induced by oxLDL through inhibition of NF-κB activation in THP-1-derived macrophages. International Journal of Molecular Medicine. 30(4). 931–938. 178 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Weiping Zhang Breakdown of academic impact, for papers by Iryna Voloshyna Breakdown of academic impact, for papers by Tomás P. Griffin Breakdown of academic impact, for papers by Jen‐Pi Tsai Breakdown of academic impact, for papers by Takashi Dan Breakdown of academic impact, for papers by Xiaohui Bian Breakdown of academic impact, for papers by Guangju Guan Breakdown of academic impact, for papers by In Hee Lee Breakdown of academic impact, for papers by Yi Song
Rankless by CCL
2026